Rivaroxaban Plus Aspirin to Manage Recurrent Venous Thromboembolic Events

Clinical trial NCT05515120 · COMPLETED

Trial details

NCT number: NCT05515120
Sponsor: Instituto Mexicano del Seguro Social
Status: COMPLETED
Phase: Phase 2, Phase 3
Study type: INTERVENTIONAL

Venous Thromboembolism Anticoagulant-induced Bleeding Venous Thromboses Pulmonary Embolism

Start date: 2021-01-03
Primary completion: 2022-01-09
Enrollment: 58

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.